宁夏定点医院新型冠状病毒肺炎患者临床路径实施和评价

Clinical pathway implementation and evaluation of COVID-19 patients in Ningxia designated hospital

目的通过对新型冠状病毒肺炎轻型、普通型单病种管理患者临床路径实施,评价同质化管理、平均住院费用、平均住院日、吻合度等应用于临床的实际效果。方法选择宁夏定点医院收治的新型冠状病毒肺炎轻型和普通型患者61例,分为临床路径组与非临床路径组(临床路径设定前),对2组患者平均住院日及平均住院费用进行对比分析,并对同质化管理进行分析。结果临床路径2组患者平均住院日(11.32±16.01)d,非入径组(13.22±3.37)d,2组比较差异有统计学意义(P<0.05)。同质化管理效果明显。患者满意率占98.4%,吻合度达到100%。结论设定NCP患者临床路径,进行单病种管理,可以更好地提高治愈率,缩短平均住院日,合理收费,能获得最大的社会效益。

Objective To evaluate the clinical effect of homogeneity management,average hospitalization cost,average length of stay,and anastomosis through the clinical pathway of light and ordinary single COVID-19(NCP)patients.Methods Sixty-one cases of NCP patients of light and normal types in Ningxia designated hospital were divided into the clinical pathway group and the non-clinical pathway group(before clinical pathway setting).The average hospitalization days and average hospitalization expenses of the two groups were compared and the homogeneity management was analyzed.Results The entry rate was 68.9%.The mean length of stay was 11.32±16.01 days in the clinical pathway group and 13.22±3.37 days in the non-approach group,there was statistically significant(P<0.05).The effect of homogenization management was obvious.The satisfaction rate of patients was 100%.The anastomosis was 100%.Conclusion Setting the clinical pathway of NCP patients and single disease management can improve the cure rate,shorten the average hospital stay and obtain the maximum social benefits.